900 reports of this reaction
1.5% of all CAFFEINE CITRATE reports
#3 most reported adverse reaction
HEPATIC ENZYME INCREASED is the #3 most commonly reported adverse reaction for CAFFEINE CITRATE, manufactured by Hikma Pharmaceuticals USA Inc.. There are 900 FDA adverse event reports linking CAFFEINE CITRATE to HEPATIC ENZYME INCREASED. This represents approximately 1.5% of all 60,859 adverse event reports for this drug.
Patients taking CAFFEINE CITRATE who experience hepatic enzyme increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEPATIC ENZYME INCREASED is a less commonly reported adverse event for CAFFEINE CITRATE, but still significant enough to appear in the safety profile.
In addition to hepatic enzyme increased, the following adverse reactions have been reported for CAFFEINE CITRATE:
The following drugs have also been linked to hepatic enzyme increased in FDA adverse event reports:
HEPATIC ENZYME INCREASED has been reported as an adverse event in 900 FDA reports for CAFFEINE CITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEPATIC ENZYME INCREASED accounts for approximately 1.5% of all adverse event reports for CAFFEINE CITRATE, making it one of the most commonly reported side effect.
If you experience hepatic enzyme increased while taking CAFFEINE CITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.